@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QW5X8DBR-Z
  skos:prefLabel "Décitabine"@fr, "Decitabine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-Z3JB8683-9 .

jvr:-C45LVXK6-1
  skos:prefLabel "Ancitabine"@fr, "Ancitabine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-Z3JB8683-9 .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-RLGZ62D2-Z
  skos:prefLabel "Antimétabolites antinéoplasiques"@fr, "Antimetabolites, Antineoplastic"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z3JB8683-9
  dc:established "1966-01-01"^^xsd:date ;
  a mesh:Descriptor, skos:Concept ;
  skos:prefLabel "Cytarabine"@en, "Cytarabine"@fr ;
  skos:hiddenLabel "Cytosar"@en, "Cytarabine Hydrochloride"@en, "Ara-C"@en, "beta-Ara C"@en, "Cytosar-U"@en, "Cytonal"@en, "Chlorhydrate de cytarabine"@fr, "Aracytine"@en ;
  skos:altLabel "04079A1RDZ"@en, "04079A1RDZ"@fr, "Arabinofuranosylcytosine"@en, "Aracytidine"@en, "2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-"@en, "2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-"@fr, "Cytosine arabinoside"@fr, "Cytosine Arabinoside"@en, "147-94-4 (Cytarabine)"@fr, "147-94-4 (Cytarabine)"@en, "Arabinosylcytosine"@en, "33K3DB6591"@fr, "33K3DB6591"@en, "69-74-9 (HCl)"@en, "69-74-9 (HCl)"@fr ;
  skos:inScheme jvr: ;
  mesh:allowableQualifier jvr:-BT300B3G-Q, jvr:-NKM836P1-M, jvr:-NFTHND7Q-8, jvr:-G30ZJ446-J, jvr:-H7K65Q8S-Z, jvr:-SBNWSM1T-R, jvr:-HQRFT0C6-B, jvr:-L6C0XPHT-4, jvr:-R3QWLHRG-V, jvr:-D0F21513-5, jvr:-G4R176S9-J, jvr:-WK5F724J-1, jvr:-W6SQV79N-S, jvr:-NB0XHT3S-N, jvr:-XV06LPML-W, jvr:-Q3979798-W, jvr:-FWD2BGQ0-9, jvr:-TJHVZCRZ-0, jvr:-T9HQD7ST-J, jvr:-THHNVC7V-3, jvr:-CB30NGKB-3, jvr:-NHL3D2X0-S, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-M63HSDM7-1 ;
  mesh:pharmacologicalAction jvr:-X5PJJJ2Q-P, jvr:-RLGZ62D2-Z, jvr:-H8LJ47P7-S ;
  skos:related jvr:-QW5X8DBR-Z ;
  skos:broader jvr:-NLS403MX-9, jvr:-V6CQJRJ4-C ;
  dc:created "1999-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D003561> ;
  skos:definition "A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)"@en ;
  dc:modified "2018-02-28"^^xsd:date ;
  skos:narrower jvr:-C45LVXK6-1 .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NLS403MX-9
  skos:prefLabel "Arabinonucleosides"@en, "Arabinonucléosides"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-Z3JB8683-9 .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-V6CQJRJ4-C
  skos:prefLabel "Cytidine"@fr, "Cytidine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-Z3JB8683-9 .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H8LJ47P7-S
  skos:prefLabel "Immunosuppresseurs"@fr, "Immunosuppressive Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-X5PJJJ2Q-P
  skos:prefLabel "Antiviral Agents"@en, "Antiviraux"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .